Is Precision BioSciences Stock a Good Investment?
Precision BioSciences Investment Advice | DTIL |
- Examine Precision BioSciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Precision BioSciences' leadership team and their track record. Good management can help Precision BioSciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Precision BioSciences' business and its evolving consumer preferences.
- Compare Precision BioSciences' performance and market position to its competitors. Analyze how Precision BioSciences is positioned in terms of product offerings, innovation, and market share.
- Check if Precision BioSciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Precision BioSciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Precision BioSciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Precision BioSciences is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Precision BioSciences Stock
Researching Precision BioSciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 43.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.0. Some equities with similar Price to Book (P/B) outperform the market in the long run. Precision BioSciences recorded a loss per share of 2.87. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 14th of February 2024.
To determine if Precision BioSciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Precision BioSciences' research are outlined below:
| Precision BioSciences generated a negative expected return over the last 90 days | |
| Precision BioSciences has high historical volatility and very poor performance | |
| Precision BioSciences has high likelihood to experience some financial distress in the next 2 years | |
| Precision BioSciences currently holds about 184.14 M in cash with (58.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66. |
Precision BioSciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Precision BioSciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Precision BioSciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Precision BioSciences' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 51.45 M.Precision BioSciences' profitablity analysis
The company has Profit Margin (PM) of (0.43) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (762.48) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $762.48.Determining Precision BioSciences' profitability involves analyzing its financial statements and using various financial metrics to determine if Precision BioSciences is a good buy. For example, gross profit margin measures Precision BioSciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Precision BioSciences' profitability and make more informed investment decisions.
Basic technical analysis of Precision Stock
As of the 20th of July, Precision BioSciences holds the Risk Adjusted Performance of (0.02), coefficient of variation of (3,971), and Variance of 15.06. Precision BioSciences technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Precision BioSciences market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Precision BioSciences is priced some-what accurately, providing market reflects its current price of 4.61 per share. Given that Precision BioSciences has information ratio of (0.06), we recommend you to check out Precision BioSciences's recent market performance to make sure the company can sustain itself at a future point.Precision BioSciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Precision BioSciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Precision BioSciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Precision BioSciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Precision BioSciences' Outstanding Corporate Bonds
Precision BioSciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Precision BioSciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Precision bonds can be classified according to their maturity, which is the date when Precision BioSciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US740189AN56 Corp BondUS740189AN56 | View | |
| PRECISION CASTPARTS P Corp BondUS740189AP05 | View | |
| PRECISION CASTPARTS P Corp BondUS740189AH88 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand Precision BioSciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Precision BioSciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 3.12 | |||
| Coefficient Of Variation | (3,971) | |||
| Standard Deviation | 3.88 | |||
| Variance | 15.06 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 16.93 | |||
| Value At Risk | (7.22) | |||
| Potential Upside | 6.77 | |||
| Skewness | (0.12) | |||
| Kurtosis | (0.29) |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 3.12 | |||
| Coefficient Of Variation | (3,971) | |||
| Standard Deviation | 3.88 | |||
| Variance | 15.06 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 16.93 | |||
| Value At Risk | (7.22) | |||
| Potential Upside | 6.77 | |||
| Skewness | (0.12) | |||
| Kurtosis | (0.29) |
Consider Precision BioSciences' intraday indicators
Precision BioSciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Precision BioSciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Precision BioSciences time-series forecasting models is one of many Precision BioSciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Precision BioSciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Precision Stock media impact
There is far too much social signal, news, headlines, and media speculation about Precision BioSciences that are available to investors today. This information is accessible both publicly - through Precision BioSciences' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Precision-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Precision BioSciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Precision BioSciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Precision BioSciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Precision BioSciences alpha.
Precision BioSciences Corporate Management
| Maurissa Messier | Senior Communications | Profile | |
| Fayaz Khazi | Chief Systems | Profile | |
| Derek Jantz | Chief CoFounder | Profile | |
| Jefferson Smith | CoFounder Officer | Profile | |
| Cassie Gorsuch | Chief Officer | Profile | |
| Bruce Stevens | Vice Compliance | Profile | |
| John Kelly | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Precision BioSciences' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.